Trial intelligence / Profile preview

Temsirolimus with Cisplatin and Gemcitabine in Advanced Urothelial Cancer

NCT01090466Phase 2Completed

Sponsor
Cardiff University
Start
Feb 2008
Primary completion
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of temsirolimus in transitional cell carcinoma of the urothelium (TCC), sponsored by Cardiff University. Started Feb 2008; status: completed.

02

Drugs

temsirolimus
03

Conditions

transitional cell carcinoma of the urothelium (TCC)

Beyond the preview

Go deeper on NCT01090466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01090466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call